Literature DB >> 35098360

Effects of cognitive rehabilitation in Parkinson disease: a meta-analysis.

Andreina Giustiniani1, Lorenza Maistrello2, Laura Danesin2, Elena Rigon2, Francesca Burgio2.   

Abstract

BACKGROUND AND OBJECTIVES: Cognitive symptoms are common in Parkinson's disease (PD) and affect patients' quality of life. Pharmacological interventions often do not improve such deficits that might benefit of cognitive rehabilitation. However, previous meta-analysis on this topic reported inconsistent results. Clarifying the efficacy of cognitive rehabilitation would be pivotal to optimize treatment and reduce care's costs. This meta-analysis aims at determining whether current literature lays in favor of the effectiveness of cognitive rehabilitation in PD and at understanding whether its effect might change depending on the trained cognitive domain.
METHODS: We searched online databases for studies concerning cognitive rehabilitation in PD. Fourteen studies encompassing 767 participants were included. Analyses were conducted for each cognitive domain separately, examining several neuropsychological measures for each function.
RESULTS: We found that rehabilitation improves global cognition, executive functions, and long- and short-term memory.
CONCLUSION: The current body of research indicates that cognitive rehabilitation improves specific cognitive deficits in PD and that it should be tailored on patients' specific impairments. These interventions should be employed considering that not all the cognitive domains might benefit of a cognitive training. Finally, the high heterogeneity among studies suggests the need for more controlled clinical trials.
© 2021. Fondazione Società Italiana di Neurologia.

Entities:  

Keywords:  Cognitive impairment; Cognitive rehabilitation; Meta-analysis; Parkinson’s disease

Mesh:

Year:  2022        PMID: 35098360     DOI: 10.1007/s10072-021-05772-4

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.830


  37 in total

1.  Reversible Pisa syndrome in patients with Parkinson's disease on rasagiline therapy.

Authors:  Alfonso Fasano; Alessandro Di Matteo; Carmine Vitale; Giovanna Squintani; Laura Ferigo; Federica Bombieri; Gabriella Santangelo; Marianna Amboni; Paolo Barone; Michele Tinazzi
Journal:  Mov Disord       Date:  2011-08-24       Impact factor: 10.338

2.  Substantia nigra hypoechogenicity in Friedreich ataxia.

Authors:  Heike Stockner; Martin Sojer; Sascha Hering; Wolfgang Nachbauer; Klaus Seppi; Christoph Schmidauer; Werner Poewe; Sylvia M Boesch
Journal:  Mov Disord       Date:  2011-12-09       Impact factor: 10.338

Review 3.  MDS research criteria for prodromal Parkinson's disease.

Authors:  Daniela Berg; Ronald B Postuma; Charles H Adler; Bastiaan R Bloem; Piu Chan; Bruno Dubois; Thomas Gasser; Christopher G Goetz; Glenda Halliday; Lawrence Joseph; Anthony E Lang; Inga Liepelt-Scarfone; Irene Litvan; Kenneth Marek; José Obeso; Wolfgang Oertel; C Warren Olanow; Werner Poewe; Matthew Stern; Günther Deuschl
Journal:  Mov Disord       Date:  2015-10       Impact factor: 10.338

4.  Nogo Receptor 1 Limits Ocular Dominance Plasticity but not Turnover of Axonal Boutons in a Model of Amblyopia.

Authors:  Michael G Frantz; Ryan J Kast; Hilary M Dorton; Katherine S Chapman; Aaron W McGee
Journal:  Cereb Cortex       Date:  2015-02-06       Impact factor: 5.357

Review 5.  MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI.

Authors:  Irene Litvan; Dag Aarsland; Charles H Adler; Jennifer G Goldman; Jaime Kulisevsky; Brit Mollenhauer; Maria C Rodriguez-Oroz; Alexander I Tröster; Daniel Weintraub
Journal:  Mov Disord       Date:  2011-06-09       Impact factor: 10.338

Review 6.  Caregiver Burden and the Nonmotor Symptoms of Parkinson's Disease.

Authors:  Jon P Hiseman; Robin Fackrell
Journal:  Int Rev Neurobiol       Date:  2017-07-21       Impact factor: 3.230

Review 7.  Prevalence and clinical aspects of mild cognitive impairment in Parkinson's disease: A meta-analysis.

Authors:  Chiara Baiano; Paolo Barone; Luigi Trojano; Gabriella Santangelo
Journal:  Mov Disord       Date:  2019-11-19       Impact factor: 10.338

Review 8.  Parkinson disease.

Authors:  Werner Poewe; Klaus Seppi; Caroline M Tanner; Glenda M Halliday; Patrik Brundin; Jens Volkmann; Anette-Eleonore Schrag; Anthony E Lang
Journal:  Nat Rev Dis Primers       Date:  2017-03-23       Impact factor: 52.329

9.  Cognitive profile of patients with newly diagnosed Parkinson disease.

Authors:  Dino Muslimovic; Bart Post; Johannes D Speelman; Ben Schmand
Journal:  Neurology       Date:  2005-10-25       Impact factor: 9.910

10.  Cognitive training for people with mild to moderate dementia.

Authors:  Alex Bahar-Fuchs; Anthony Martyr; Anita My Goh; Julieta Sabates; Linda Clare
Journal:  Cochrane Database Syst Rev       Date:  2019-03-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.